Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
800
Trial Sponsor
Clinical Trial Start Date
2024
0Primary Completion Date
2027
0Study Completion Date
2027
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Interventional Trial Phase
Phase 20
Official Name
Psilocybin vs Ketamine for Alcohol Use Disorder0
Last Updated
May 8, 2024
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Investigator0
Participant0
Other attributes
Intervention Treatment
Ketamine0
Psilocybin0
Study summary
This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of oral psilocybin. Arm 2 subjects (n=40) will receive individual psychotherapy sessions and a 0.75 mg/kg dose of intramuscular ketamine.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
